Solvay SA (OTC:SVYSY) will release the fourth quarter earnings for 2007 on February 15.
Based in
The pharmaceuticals segment engages in therapeutic fields of cardiometabolic, neuroscience, flu vaccines, pancreatic enzymes, gastroenterology and hormone therapy for men and women.
The chemicals segment focuses on fluorinated products, multiple soda bicarbonate applications, ultra-pure barium and strontium carbonates, advanced f unctional minerals and ultra pure grades of hydrogen peroxide.
The plastics segment focuses on high-performance specialty polymers, such as fluorinated polymers, elastopolymers and fluids, barrier materials, polyarylamides, polysulfones, high-performance polyamides, liquid crystal polymers and fuel systems.
For more Earnings related events or to post your own events, visit: